Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Riedel

Showing results (71-80 of 176) with videos related to

Pageof 18
Sort By:
International Journal of Bipolar Disorders|April 1, 2022
Omega-3 fatty acids in bipolar patients with a low omega-3 index and reduced heart rate variability: the "BIPO-3" trialMichael Berger, Florian Seemüller, Alessandra Voggt, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|November 22, 2011
The potential role of Marginal Structural Models (MSMs) in testing the effectiveness of antidepressants in the treatment of patients with major depression in everyday clinical practiceEmanuel Severus, Ilya Lipkovich, Florian Seemüller, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2005
SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD)Oliver Pogarell, Gabriele Poepperl, Christoph Mulert, et al.
Acta Psychiatrica Scandinavica|November 3, 2020
Combining machine learning algorithms for prediction of antidepressant treatment responseAlexander Kautzky, Hans-Juergen Möller, Markus Dold, et al.
Journal of Affective Disorders|April 7, 2009
Functional MRI study of memory-related brain regions in patients with depressive disorderNatalie S Werner, Thomas Meindl, Julia Materne, et al.
Journal of Clinical Psychopharmacology|December 31, 2010
Effectiveness of quetiapine in outpatients with schizophrenia assessed under "real-life" conditions: a German clinical-practice evaluation programmeMichael Riedel, Emanuel Severus, Rebecca Schennach-Wolff, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 11, 2005
IL-2 and IL-4 polymorphisms as candidate genes in schizophreniaMarkus J Schwarz, Holger Krönig, Michael Riedel, et al.
CNS Drugs|July 4, 2013
Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendationsAnja Cerovecki, Richard Musil, Ansgar Klimke, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 27, 2004
Risperidone plasma levels, clinical response and side-effectsMichael Riedel, M J Schwarz, M Strassnig, et al.
Biological Psychiatry|December 17, 2003
Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorderOliver Pogarell, Christine Hamann, Gabriele Pöpperl, et al.
Pageof 18

Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
International Journal of Bipolar Disorders|April 1, 2022
Omega-3 fatty acids in bipolar patients with a low omega-3 index and reduced heart rate variability: the "BIPO-3" trialMichael Berger, Florian Seemüller, Alessandra Voggt, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|November 22, 2011
The potential role of Marginal Structural Models (MSMs) in testing the effectiveness of antidepressants in the treatment of patients with major depression in everyday clinical practiceEmanuel Severus, Ilya Lipkovich, Florian Seemüller, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2005
SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD)Oliver Pogarell, Gabriele Poepperl, Christoph Mulert, et al.
Acta Psychiatrica Scandinavica|November 3, 2020
Combining machine learning algorithms for prediction of antidepressant treatment responseAlexander Kautzky, Hans-Juergen Möller, Markus Dold, et al.
Journal of Affective Disorders|April 7, 2009
Functional MRI study of memory-related brain regions in patients with depressive disorderNatalie S Werner, Thomas Meindl, Julia Materne, et al.
Journal of Clinical Psychopharmacology|December 31, 2010
Effectiveness of quetiapine in outpatients with schizophrenia assessed under "real-life" conditions: a German clinical-practice evaluation programmeMichael Riedel, Emanuel Severus, Rebecca Schennach-Wolff, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 11, 2005
IL-2 and IL-4 polymorphisms as candidate genes in schizophreniaMarkus J Schwarz, Holger Krönig, Michael Riedel, et al.
CNS Drugs|July 4, 2013
Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendationsAnja Cerovecki, Richard Musil, Ansgar Klimke, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 27, 2004
Risperidone plasma levels, clinical response and side-effectsMichael Riedel, M J Schwarz, M Strassnig, et al.
Biological Psychiatry|December 17, 2003
Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorderOliver Pogarell, Christine Hamann, Gabriele Pöpperl, et al.
Pageof 18